These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9723276)

  • 1. Drug monitoring of mycophenolic acid in the early period after renal transplantation.
    Krumme B; Wollenberg K; Kirste G; Schollmeyer P
    Transplant Proc; 1998 Aug; 30(5):1773-4. PubMed ID: 9723276
    [No Abstract]   [Full Text] [Related]  

  • 2. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
    Vathsala A; Lu YM
    Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
    Kuypers DR; Evenepoel P; Maes BD; Coosemans W; Pirenne J; Vanrenterghem YF
    Transplant Proc; 2002 Jun; 34(4):1164-70. PubMed ID: 12072305
    [No Abstract]   [Full Text] [Related]  

  • 4. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
    Cubas A; Herrero JC; Morales E; Carreño A; Dominguez-Gil B; Cirujeda A; Praga M; Ortuño T; Hernandez E; Delgado M; Andres A; Morales JM
    Transplant Proc; 1999 Sep; 31(6):2265-6. PubMed ID: 10500570
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
    Rudich SM; Bhaduri S; Chang T; Cahn J; Katznelson S; Perez RV
    Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
    [No Abstract]   [Full Text] [Related]  

  • 6. A one-center experience with a short course of mycophenolic acid.
    Stephan A; Barbari A; Kamel G; Aoun S; Masri MA
    Transplant Proc; 1999 Dec; 31(8):3289-90. PubMed ID: 10616479
    [No Abstract]   [Full Text] [Related]  

  • 7. Could prophylactic monoclonal antibody improve kidney graft survival?
    Pourmand G; Saraji A; Salem S; Mehrsai A; Nikoobakht MR; Taherimahmoudi M; Rezaeidanesh M; Asadpour A
    Transplant Proc; 2009 Sep; 41(7):2794-6. PubMed ID: 19765437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
    Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
    Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation.
    Munoz MA; Andrés A; Gallego R; Morales E; Morales JM; Aguado JM; Lumbreras C; Torres A; Rodicio JL; Praga M
    Transplant Proc; 2002 Feb; 34(1):97. PubMed ID: 11959202
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
    Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Marcas LI; Manresa JM; Masramón J
    Transplant Proc; 1998 Aug; 30(5):2226-7. PubMed ID: 9723449
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
    Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
    [No Abstract]   [Full Text] [Related]  

  • 14. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF; Górriz JL; Sancho A; Avila A; Alcoy E; Pallardó LM
    Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil in living donor renal allograft recipients.
    Park K; Moon JI; Kim SI; Kim YS
    Transplant Proc; 1999; 31(1-2):1133. PubMed ID: 10083506
    [No Abstract]   [Full Text] [Related]  

  • 16. Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.
    Folkmane I; Bicans J; Amerika D; Chapenko S; Murovska M; Rosentals R
    Transplant Proc; 2001; 33(7-8):3209-10. PubMed ID: 11750377
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E; Remport A; Járay J; Máthé Z; Borka P; Perner F
    Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
    Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract]   [Full Text] [Related]  

  • 19. ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.
    Kumar MS; Cahill K; Kumar AM; Panigrahi D; Seirka D; Singleton R; al-Abdullah IH; Laskow DA
    Transplant Proc; 1998 Jun; 30(4):1351-2. PubMed ID: 9636549
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.